Done Deal: Organon Completes Acquisition of Dermavant
The Dermatology Digest
OCTOBER 28, 2024
The FDA is reviewing a supplemental New Drug Application (sNDA) for tapinarof cream, 1%, as a potential treatment for atopic dermatitis (AD) in adults and children two years of age and older, with Prescription Drug User Fee Act (PDUFA) action expected in the fourth quarter of calendar year 2024.
36 
Let's personalize your content